or Try an Advanced Search...

    Antineoplastic Drugs Stocks List

    Symbol Grade Name % Change
    ACHL B Achilles Therapeutics plc -0.47
    AADI C Aadi Biosciences, Inc. 2.70
    SLS C SELLAS Life Sciences Group, Inc. -2.42
    AVBP C ArriVent BioPharma, Inc. -2.39
    PYXS C Pyxis Oncology, Inc. -44.63
    MBRX C Moleculin Biotech, Inc. 2.25
    APLM D Apollomics Inc. -32.71
    CRDF D Cardiff Oncology, Inc. -0.59
    SNDX F Syndax Pharmaceuticals, Inc. -1.97
    CNTX F Context Therapeutics Inc. -5.83
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Cancer Clinical Medicine Medicine Biopharmaceutical Cancer Treatment Chemotherapy Immunotherapy Oncology Occupational Safety And Health Solid Tumors Cancer Immunotherapy Checkpoint Inhibitor Immune System Melanoma Milatuzumab Pembrolizumab Stem Cell Actinic Keratosis Adjunctive Therapy Adoptive Cell Transfer

    Related ETFs - A few ETFs which own one or more of the above listed Antineoplastic Drugs stocks.

    Symbol Grade Name Weight
    JFWD B Jacob Funds Inc. Jacob Forward ETF 2.78
    CNCR F Loncar Cancer Immunotherapy ETF 2.42
    IDNA D iShares Genomics Immunology and Healthcare ETF 2.38
    WDNA D WisdomTree BioRevolution Fund 1.93
    BBP C BioShares Biotechnology Products Fund 1.48
    View all Antineoplastic Drugs ETFs...
    Compare ETFs
    Compare CNCR to BBP Compare CNCR to IDNA Compare JFWD to WDNA

        Antineoplastic Drugs Stocks Recent News

        Date Stock Title
        Nov 21 PYXS Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results
        Nov 21 PYXS Pyxis stock craters 46% amid Phase 1 data, William Blair downgrade
        Nov 21 APLM Apollomics’ Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split
        Nov 20 PYXS Pyxis Oncology plummets 38% on preliminary phase 1 data for cancer asset
        Nov 20 PYXS Pyxis Oncology Announces Favorable Preliminary PYX-201 Clinical Phase 1 Part 1 Data
        Nov 19 ACHL US Penny Stocks To Watch In November 2024
        Nov 19 CRDF Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS mutated mCRC
        Nov 19 ACHL Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
        Nov 18 SNDX Syndax secures FDA OK for new kind of leukemia drug
        Nov 18 SNDX FDA approves Syndax’s Revuforj to treat leukaemia
        Nov 16 SLS We're A Little Worried About SELLAS Life Sciences Group's (NASDAQ:SLS) Cash Burn Rate
        Nov 15 SNDX Syndax wins FDA approval for leukemia drug revumenib
        Nov 15 SNDX Syndax Announces FDA Approval of Revuforj® (revumenib), the First and Only Menin Inhibitor to Treat Adult and Pediatric Patients with Relapsed or Refractory Acute Leukemia with a KMT2A Translocation
        Nov 15 AVBP ArriVent BioPharma GAAP EPS of -$0.61 beats by $0.11
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Cancer Clinical Medicine Medicine Biopharmaceutical Cancer Treatment Chemotherapy Immunotherapy Oncology Occupational Safety And Health Solid Tumors Cancer Immunotherapy Checkpoint Inhibitor Immune System Melanoma Milatuzumab Pembrolizumab Stem Cell Actinic Keratosis Adjunctive Therapy Adoptive Cell Transfer
        Antineoplastic Drugs

        Antineoplastic drugs, also known as cytotoxic drugs, are a type of medication used to treat cancer. They work by interfering with the growth and spread of cancer cells. These drugs can be used alone or in combination with other treatments, such as surgery, radiation therapy, or hormone therapy.

        Browse All Tags